FDA Approved: REPAGLINIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application from Chartwell RX, LLC for repaglinide, enabling the generic version of the drug to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)

Snippet

SUPPL AP for REPAGLINIDE (REPAGLINIDE)